ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 880,15
-0,33%
Dow Jones
44 556,04
0,30%
DAX
21 441,84
-0,32%
Brent Oil
75,33
-0,80%
Bitcoin
97 772,43
-0,09%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Prothena Corporation Plc (0Y3M) Cours

Prothena Corporation Plc

Prothena Corporation Plc (0Y3M)

LSE
14,65
0,00
( 0,00% )
Mis à jour : 01:00:00
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
14,65
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
14,65 Plage de 52 semaines 14,65
Cap du marché
786,441M
Clôture Veille
14,65
Ouverture
-
Dernière Transaction
4
@
16.9024
(O)
Dernière heure de transaction
21:57:39
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 319
Actions en circulation
53 682 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-5,29
Bénéfice par action (BPA)
-2,74
Chiffre d'affairess
91,37M
Bénéfice net
-147,03M

À propos de Prothena Corporation Plc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.prothena.com
Siège social
Dublin, Irl
Fondé
-
Prothena Corporation Plc est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0Y3M. Le dernier cours de clôture d'Prothena était de US$14,65. Au cours de la dernière année, les actions de Prothena ont été négociées dans une fourchette de prix de US$ 14,65 à US$ 14,65.

Prothena compte actuellement 53 682 000 actions en circulation. La capitalisation boursière d'Prothena est de US$786,44 million. Prothena a un ratio cours/bénéfice (ratio PE) de -5.29.

0Y3M Dernières nouvelles

Plus de nouvelles

Prothena to Report Third Quarter 2022 Financial Results on November 3rd

Prothena to Report Third Quarter 2022 Financial Results on November 3rd DUBLIN, Ireland, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

27 Octobre 2022
GlobeNewswire Inc.

Prothena to Participate in Upcoming Healthcare Conferences

Prothena to Participate in Upcoming Healthcare Conferences DUBLIN, Ireland, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology...

01 Septembre 2022
GlobeNewswire Inc.

Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors

Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors DUBLIN, Ireland, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc...

01 Septembre 2022
GlobeNewswire Inc.

Prothena Reports Second Quarter 2022 Financial Results and Business Highlights

Prothena Reports Second Quarter 2022 Financial Results and Business Highlights Net cash used in operating and investing activities was $35.5 million in the second quarter and $72.9 million...

08 Août 2022
GlobeNewswire Inc.

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) DUBLIN, Ireland, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

02 Août 2022
GlobeNewswire Inc.

Prothena to Report Second Quarter 2022 Financial Results on August 8th

Prothena to Report Second Quarter 2022 Financial Results on August 8th DUBLIN, Ireland, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

01 Août 2022
GlobeNewswire Inc.

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) DUBLIN, Ireland, July 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

01 Juillet 2022
GlobeNewswire Inc.

Prothena to Participate in Jefferies Healthcare Conference

Prothena to Participate in Jefferies Healthcare Conference DUBLIN, Ireland, June 02, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology...

02 Juin 2022
GlobeNewswire Inc.

Prothena Reports First Quarter 2022 Financial Results and Business Highlights

Prothena Reports First Quarter 2022 Financial Results and Business Highlights Net cash used in operating and investing activities was $37.4 million in the first quarter; quarter-end cash and...

05 Mai 2022
GlobeNewswire Inc.

Prothena to Report First Quarter 2022 Financial Results on May 5th

Prothena to Report First Quarter 2022 Financial Results on May 5th DUBLIN, Ireland, April 28, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

28 Avril 2022
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10014.6514.6514.6537414.65DE
40014.6514.6514.6545814.65DE
120014.6514.6514.65131914.65DE
260014.6514.6514.65113714.65DE
520014.6514.6514.65105014.65DE
1560014.6514.6514.6539414.65DE
2600014.6514.6514.6525614.65DE

0Y3M - Frequently Asked Questions (FAQ)

What is the current Prothena share price?
The current share price of Prothena is US$ 14,65
How many Prothena shares are in issue?
Prothena has 53 682 000 shares in issue
What is the market cap of Prothena?
The market capitalisation of Prothena is USD 786,44M
What is the 1 year trading range for Prothena share price?
Prothena has traded in the range of US$ 14,65 to US$ 14,65 during the past year
What is the PE ratio of Prothena?
The price to earnings ratio of Prothena is -5,29
What is the cash to sales ratio of Prothena?
The cash to sales ratio of Prothena is 8,51
What is the reporting currency for Prothena?
Prothena reports financial results in USD
What is the latest annual turnover for Prothena?
The latest annual turnover of Prothena is USD 91,37M
What is the latest annual profit for Prothena?
The latest annual profit of Prothena is USD -147,03M
What is the registered address of Prothena?
The registered address for Prothena is 77 SIR JOHN ROGERSON’S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN, D02 VK60
What is the Prothena website address?
The website address for Prothena is www.prothena.com
Which industry sector does Prothena operate in?
Prothena operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
XSGXeros Technology Group Plc
0,725p
(38,10%)
12,81M
SYMESupply@me Capital Plc
0,0034p
(23,64%)
54,98M
GFINGfinity Plc
0,0675p
(22,73%)
6,59M
OBDOxford Biodynamics Plc
0,60p
(20,00%)
246,02M
STXShield Therapeutics Plc
3,35p
(17,54%)
7,11M
TRCThe Revel Collective Plc
0,175p
(-22,22%)
3,07M
KRPZKropz Plc
0,90p
(-21,74%)
127,58k
PRDPredator Oil & Gas Holdings Plc
4,40p
(-19,27%)
17,31M
ROQRoquefort Therapeutics Plc
2,25p
(-15,09%)
472,1k
AXLArrow Exploration Corp.
19,75p
(-13,19%)
3,8M
NTVONativo Resources Plc
0,0017p
(0,00%)
479,88M
OBDOxford Biodynamics Plc
0,60p
(20,00%)
246,02M
WBIWoodbois Limited
0,0825p
(0,00%)
223,54M
MSMNMosman Oil And Gas Limited
0,041p
(-5,75%)
187,69M
EMEEmpyrean Energy Plc
0,145p
(-7,94%)
116,02M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
0Y3M
Prothena
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces